Case Studies

GMP Lentivirus Production Platform - LVV Turbo™

Enabling Ex Vivo and In Vivo CAR-T Therapeutics with a High-Yield, Cost-Efficient cGMP Lentiviral Vector Platform

Please fill out this form to access the resource.

Please fill out this form to access the resource